{"schema_version":"secwatch.filing_event.v1","accession":"0001903596-23-000929","form_type":"8-K","ticker":"KAYS","cik":"0001530746","company_name":"Kaya Holdings, Inc.","filed_at":"2023-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.392526+00:00","generated_at":"2026-06-07T20:16:53.672689+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Kaya Holdings CEO discusses upcoming psilocybin treatment center in podcast","bullets":["CEO Craig Frank and consultant Dave Jones feature on Investor Ideas Potcast about The Sacred Mushroom center.","Treatment center located on 11,000 sq ft top floor of Falcon Building in downtown Portland, Oregon.","Company plans to use natural psilocybin and psilocin, avoiding lengthy FDA process.","Offers both private and group experiences, including microdosing options at lower prices.","Kaya Holdings is a fully reporting OTC listed company (KAYS) with cannabis and psychedelic operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001903596-23-000929","json":"https://secwatch.observer/filing/0001903596-23-000929.json","markdown":"https://secwatch.observer/filing/0001903596-23-000929.md","text":"https://secwatch.observer/filing/0001903596-23-000929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530746/000190359623000929/0001903596-23-000929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530746/000190359623000929/kays_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T20:16:53.672689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}